Monopar Therapeutics Quarterly Other Assets, Current in USD from Q4 2019 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of current assets classified as other.
Summary: Monopar Therapeutics quarterly Other Assets, Current history and growth rate from Q4 2019 to Q4 2024.
Monopar Therapeutics Other Assets, Current for the quarter ending December 31, 2024 was $78.9K, a 18.7% increase year-over-year.

Other Assets, Current, Quarterly (USD)

Other Assets, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$78.9K	+$12.4K	+18.7%	Dec 31, 2024	10-K	2025-03-31
Q3 2024	$49.6K	-$23.6K	-32.3%	Sep 30, 2024	10-Q	2024-11-08
Q2 2024	$61K	-$48.9K	-44.5%	Jun 30, 2024	10-Q	2024-08-09
Q1 2024	$119K	+$12.2K	+11.4%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$66.4K	+$20.5K	+44.5%	Dec 31, 2023	10-K	2025-03-31
Q3 2023	$73.2K	+$17.5K	+31.4%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$110K	-$79.3K	-41.9%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$107K	-$86.8K	-44.8%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$46K	-$172K	-78.9%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$55.7K	-$51.1K	-47.8%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$189K	+$93.6K	+98%	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$194K			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$218K	+$155K	+247%	Dec 31, 2021	10-K	2023-03-23
Q3 2021	$107K			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$95.6K			Jun 30, 2021	10-Q	2021-08-12
Q4 2020	$62.7K	+$47K	+299%	Dec 31, 2020	10-K	2022-03-24
Q4 2019	$15.7K			Dec 31, 2019	10-K	2021-03-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.